Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels-Reference-Cited by-同舟云学术

Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels

Published:2012-08-09 Issue:8 Volume:3 Page:811-823
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bressanin Daniela¹,Evangelisti Camilla²,Ricci Francesca³,Tabellini Giovanna⁴,Chiarini Francesca²,Tazzari Pier Luigi³,Melchionda Fraia⁵,Buontempo Francesca¹,Pagliaro Pasqualepaolo³,Pession Andrea⁵,McCubrey James A.⁶,Martelli Alberto M.¹²

Affiliation:

1. Department of Human Anatomy, University of Bologna, Bologna, Italy

2. Institute of Molecular Genetics, National Research Council-Rizzoli Orthopedic Institute, Bologna, Italy

3. Immunohaematology and Transfusion Center, Policlinico S.Orsola-Malpighi, Bologna, Italy

4. Department of Biomedical Sciences and Biotechnology, University of Brescia, Brescia, Italy

5. Paediatric Oncology and Hematology Unit Lalla Seràgnoli, University of Bologna, Bologna, Italy

6. Department of Microbiology & Immunology, School of Medicine, East Carolina University, Greenville, NC, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucocorticoid Therapy in Acute Lymphoblastic Leukemia: Navigating Short-Term and Long-Term Effects and Optimal Regimen Selection;Current Hematologic Malignancy Reports;2024-06-13

2. The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies;Expert Review of Anticancer Therapy;2024-05-08

3. Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL);BioImpacts;2023-10-24

4. Targeted delivery of AZD5363 to T-cell acute lymphocytic leukemia by mSiO2-Au nanovehicles;Colloids and Surfaces B: Biointerfaces;2023-10

5. WDR54 exerts oncogenic roles in T‐cell acute lymphoblastic leukemia;Cancer Science;2023-06-11